30
Participants
Start Date
March 12, 2024
Primary Completion Date
September 13, 2025
Study Completion Date
December 31, 2025
TK216+Vincristin
TK216 was continuously administered for 14 days，then rest for 14 days. Vincristin is given before TK216 only in the first day of each cycle, the first cycle of VCR is 0.75mg/m\^2 and 1.5mg/m\^2 from the second cycle，every 28 days is a study cycle.
RECRUITING
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
RECRUITING
Peking University People's Hospital, Beijing
RECRUITING
Shanghai Sixth People's Hospital, Shanghai
RECRUITING
Tianjin Medical University Cancer Institude & Hospital, Tianjin
RECRUITING
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Henan Provincial People's Hospital, Zhengzhou
Shanghai Pharmaceuticals Holding Co., Ltd
INDUSTRY